“Pharmacological Management of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)”, Faridpur Med Coll J, vol. 21, no. 2, pp. 51–60, Jun. 2026, doi: 10.3329/fmcj.v21i2.90822.